Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer

MC Lim, YJ Song, SS Seo, CW Yoo, S Kang… - Oncology Research …, 2010 - karger.com
The objective of this review is to discuss the common surgical strategy of cytoreductive
surgery after neoadjuvant chemotherapy, with an emphasis on incorporating extensive …

Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial

MC Lim, SJ Chang, B Park, HJ Yoo, CW Yoo… - JAMA …, 2022 - jamanetwork.com
Importance Ovarian cancer has the highest mortality rate among gynecologic malignant
tumors. Data are lacking on the survival benefit of hyperthermic intraperitoneal …

[HTML][HTML] Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement

MC Lim, M Lee, SH Shim, EJ Nam, JY Lee… - Journal of …, 2017 - ncbi.nlm.nih.gov
Clinical practice guidelines for gynecologic cancers have been developed by academic
society from several countries. Each guideline reflected their own insurance system and …

[HTML][HTML] Prediction of optimal debulking surgery in ovarian cancer

YJ Song - Gland surgery, 2021 - ncbi.nlm.nih.gov
The mainstay management of advanced ovarian cancer is maximal cytoreductive surgery
followed by chemotherapy. Neoadjuvant chemotherapy (NACT) and interval debulking …

Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a …

MC Lim, S Kang, J Choi, YJ Song, S Park… - Annals of surgical …, 2009 - Springer
Background The objective of the current study was to evaluate the toxicities and treatment
response of intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) in patients …

[HTML][HTML] Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with …

SH Shim, MC Lim, HJ Kim, M Lee, EJ Nam, JY Lee… - PLoS …, 2018 - journals.plos.org
Objective This study aims to analyze the published literatures on the effect of less radical
fertility-preserving procedures, such as conization or simple trachelectomy, on oncological …

Learning curve analysis of laparoscopic radical hysterectomy and lymph node dissection in early cervical cancer

JH Hwang, HJ Yoo, J Joo, S Kim, MC Lim… - European Journal of …, 2012 - Elsevier
OBJECTIVE: We aimed to evaluate the learning curve for laparoscopic radical hysterectomy
and lymph node dissection (LRHND) in uterine cervical cancer and to compare the …

Silibinin Inhibits Tumor Growth through Downregulation of Extracellular Signal-Regulated Kinase and Akt in Vitro and in Vivo in Human Ovarian Cancer Cells

HJ Cho, DS Suh, SH Moon, YJ Song… - Journal of agricultural …, 2013 - ACS Publications
Anticancer activity of silibinin, a flavonoid, has been demonstrated in various cancer cell
types. However, the underlying mechanisms were not elucidated in human ovarian cancer …

[HTML][HTML] Di-(2-ethylhexyl) Phthalate Triggers Proliferation, Migration, Stemness, and Epithelial–Mesenchymal Transition in Human Endometrial and Endometriotic …

HG Kim, YS Lim, S Hwang, HY Kim, Y Moon… - International Journal of …, 2022 - mdpi.com
Di-(2-ethylhexyl) phthalate (DEHP) is a frequently used plasticizer that may be linked to the
development of endometriosis, a common gynecological disorder with a profound impact on …

Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2

SB Rho, YJ Song, MC Lim, SH Lee, BR Kim, SY Park - Cellular signalling, 2012 - Elsevier
Programmed cell death 6 (PDCD6) was originally found as a pro-apoptotic protein, but its
molecular mechanism is not well understood. In this study, we have attempted to investigate …